In vitro bioactivity of laser ablation pseudowollastonite coating

Fabrication and Characterization of Polycaprolactone-Baghdadite Nanofibers by Electrospinning Method for Tissue Engineering Applications

This work investigates the essential constituents, production methods, and properties of polycaprolactone (PCL) and Baghdadite fibrous scaffolds. In this research, electrospinning was used to produce fiber ropes. In this study, the Baghdadite powder was synthesized using the sol-gel method and incorporated into PCL's polymeric matrix in formic acid and acetic acid solvents. The present work examined PCL-Baghdadite fibrous scaffolds at 1%, 3%, and 5 wt% for morphology, fiber diameter size, hydrophilicity, porosity, mechanical properties, degradability, and bioactivity. The introduction of Baghdadite nanopowder into pure PCL scaffolds reduced fiber diameter. The wetting angle decreased when Baghdadite nanopowder was added to fibrous scaffolds. Pure PCL reduced the wetting angle from 93.20° to 70.53°. Fibrous PCL scaffolds with Baghdadite nanopowder have better mechanical characteristics. The tensile strength of pure PCL fibers was determined at 2.08 ± 0.2 MPa, which was enhanced by up to 3 wt% by adding Baghdadite nanopowder. Fiber elasticity increased with tensile strength. Baghdadite at a 5% weight percentage reduced failure strain percentage. Fibers with more Baghdadite nanopowder biodegrade faster. Adding Baghdadite ceramic nanoparticles resulted in increased bioactivity and caused scaffolds to generate hydroxyapatite. The results show that Baghdadite PCL-3 wt% fibers have promising shape, diameter, and mechanical qualities. After 24 h, L-929 fibroblast cell viability was greater in the scaffold with 3% Baghdadite weight compared to the pure PCL. PCL-3 wt% Baghdadite fibers generated hydroxyapatite on the surface and degraded well. Based on the above findings, PCL fibers having 3 wt% of Baghdadite are the best sample for tissue engineering applications that heal flaws.

Recent advances on bioactive baghdadite ceramic for bone tissue engineering applications: 20 years of research and innovation (a review)

Various artificial bone graft substitutes based on ceramics have been developed over the last 20 years. Among them, calcium-silicate-based ceramics, which are osteoconductive and can attach directly to biological organs, have received great attention for bone tissue engineering applications. However, the degradation rate of calcium-silicate and bone formation is often out of balance, resulting in stress shielding (osteopenia). A new strategy to improve the drawbacks of these ceramics is incorporating trace elements such as Zn, Mg, and Zr into their lattice structures, enhancing their physical and biological properties. Recently, baghdadite (Ca₃ZrSi₂O₉) ceramic, one of the most appealing calcium-silicate-based ceramics, has demonstrated high bioactivity, biocompatibility, biodegradability, and cell interaction. Because of its physical, mechanical, and biological properties and ability to be shaped using various fabrication techniques, baghdadite has found high potential in various biomedical applications such as coatings, fillers, cement, scaffolds, and drug delivery systems. Undoubtedly, there is a high potential for this newly developed ceramic to contribute significantly to therapies to provide a tremendous clinical outcome. This review paper aims to summarize and discuss the most relevant studies performed on baghdadite-based ceramics and composites by focusing on their behavior in vivo and in vitro.

Orthosilicic acid, Si(OH)4, stimulates osteoblast differentiation in vitro by upregulating miR-146a to antagonize NF-κB activation

Accumulating evidence over the last 40years suggests that silicate from dietary as well as silicate-containing biomaterials is beneficial to bone formation. However, the exact biological role(s) of silicate on bone cells are still unclear and controversial. Here, we report that orthosilicic acid (Si(OH)4) stimulated human mesenchymal stem cells (hMSCs) osteoblastic differentiation in vitro. To elucidate the possible molecular mechanisms, differential microRNA microarray analysis was used to show that Si(OH)4 significantly up-regulated microRNA-146a (miR-146a) expression during hMSC osteogenic differentiation. Si(OH)4 induced miR-146a expression profiling was further validated by quantitative RT-PCR (qRT-PCR), which indicated miR-146a was up-regulated during the late stages of hMSC osteogenic differentiation. Inhibition of miR-146a function by anti-miR-146a suppressed osteogenic differentiation of MC3T3 pre-osteoblasts, whereas Si(OH)4 treatment promoted osteoblast-specific genes transcription, alkaline phosphatase (ALP) production, and mineralization. Furthermore, luciferase reporter assay, Western blotting, enzyme-linked immunosorbent assay (ELISA), and immunofluorescence showed that Si(OH)4 decreased TNFα-induced activation of NF-κB, a signal transduction pathway that inhibits osteoblastic bone formation, through the known miR-146a negative feedback loop. Our studies established a mechanism for Si(OH)4 to promote osteogenesis by antagonizing NF-κB activation via miR-146a, which might be interesting to guide the design of osteo-inductive biomaterials for treatments of bone defects in humans.

STATEMENT OF SIGNIFICANCE

Accumulating evidence over 40years suggests that silicate is beneficial to bone formation. However, the biological role(s) of silicate on bone cells are still unclear and controversial. Here, we report that Si(OH)4, the simplest form of silicate, can stimulate human mesenchymal stem cells osteoblastic differentiation. We identified that miR-146a is the expression signature in bone cells treated with Si(OH)4. Further analysis of miR-146a in bone cells reveals that Si(OH)4 upregulates miR-146a to antagonize the activation of NF-κB. Si(OH)4 was also shown to deactivate the same NF-κB pathway to suppress osteoclast formation. Our findings are important to the development of third-generation cell-and gene affecting biomaterials, and suggest silicate and miR-146a can be used as pharmaceuticals for bone fracture prevention and therapy.

Bioactivity enhancement of titanium induced by Nd:Yag laser pulses

PURPOSE

In this research, the effect of laser properties such as laser power and laser dwell time on the surface morphology and oxidizing of titanium have been investigated in order to enhance the bioactivity of laser textured titanium sheets.

METHODS

The Ti samples were irradiated with nanosecond pulses to create the predetermined point patterns on the surface of sample sheets with specific laser parameters. Final bioactivity of the treated samples were evaluated through the use of simulated body fluid (SBF), followed by material characterization techniques such as X-ray diffraction (XRD) and energy dispersive (EDX).

RESULTS

It was observed that by increasing the roughness of the titanium surface samples using a range of dwelling time, and with different powers, titania with higher levels of surface energy in micro/sub-micro scales are produced. The use of laser results in a one-step heat increase and the oxidation of titanium, which results in creation of titania with higher cell adhesion abilities.

CONCLUSIONS

It was concluded that the variation of the surface roughness, surface morphology, and oxidation level of the material has a direct effect on the cell adhesion rate to the surface of the titanium. Upon completion of the analysis, it is concluded that using a higher power and a lower dwelling time results in better bioactivity improvement than using higher dwelling times and lower powers.

The enhancement of bone regeneration by a combination of osteoconductivity and osteostimulation using β-CaSiO3/β-Ca3(PO4)2 composite bioceramics

β-Tricalcium phosphate (β-TCP) is osteoconductive, while β-calcium silicate (β-CS) is bioactive with osteostimulative properties. Porous β-CaSiO(3)/β-Ca(3)(PO(4))(2) composite bioceramic scaffolds with various β-TCP:β-CS ratios were designed to combine both osteoconductivity and osteostimulation in order to enhance bone regeneration. The composite scaffolds were implanted in critical sized femur defects (6×12 mm) for 4, 12 and 26weeks with pure β-TCP and β-CS scaffolds as the controls. The in vivo biodegradation and bone regeneration of the specimens were investigated using sequential histological evaluations, immunohistochemical examination and micro-computed tomography technology. The results showed that the scaffolds with 50 and 80 wt.% β-CS dramatically enhanced the amount of newly formed bone and reduced the degradation rate. In contrast, porous β-CS displayed poor new bone formation due to its rapid degradation, while porous β-TCP showed moderate bone regeneration starting on the surface of the implants, due to a lack of osteostimulation. More importantly, the scaffolds with 50 and 80 wt.% β-CS not only had excellent osteoconductivity, but also stimulated rapid bone formation, and they could degrade progressively at a rate matching the regeneration of new bone. In summary, our findings indicated that the degradation rate and bioactivity of β-CS/β-TCP composite bioceramic scaffolds could be adjusted by controlling the ratio of β-CS to β-TCP, suggesting the potential application of β-CS/β-TCP composite bioceramic scaffolds with 50 and 80 wt.% β-CS component in hard tissue regeneration and bone tissue engineering.

Influence of thermal treatment on the "in vitro" bioactivity of wollastonite materials

The aim of this work was to study the influence of the composition and thermal treatment of the in vitro bioactivity of wollastonite materials obtained by sol-gel method. For this purpose, gels in the system SiO(2)-CaO were obtained applying calcium nitrate and tetraethoxysilicate as precursors. The gels were heated to 700 °C and then sintered up to 1400 °C. The bioactivity of the gel-derived materials in simulated body fluid (SBF) was investigated and characterized. Additional changes in ionic concentration, using inductively couple plasma atomic emission spectroscopy (ICP-AES), were determined. The results showed that all materials obtained were bioactive and indicate that the absence of phosphorous in the material composition is not an essential requirement for the development of a Hydroxyapatite layer. The bioactivity was influenced by the thermal treatment, the different phases (glass-phase, wollastonite and pseudowollastonite) as well as the porous size. On the gel-derived materials the bioactivity decreased with the sintering temperature.

Nanostructured glass-ceramic coatings for orthopaedic applications

Glass-ceramics have attracted much attention in the biomedical field, as they provide great possibilities to manipulate their properties by post-treatments, including strength, degradation rate and coefficient of thermal expansion. In this work, hardystonite (HT; Ca2ZnSi2O7) and sphene (SP; CaTiSiO5) glass-ceramic coatings with nanostructures were prepared by a plasma spray technique using conventional powders. The bonding strength and Vickers hardness for HT and SP coatings are higher than the reported values for plasma-sprayed hydroxyapatite coatings. Both types of coatings release bioactive calcium (Ca) and silicon (Si) ions into the surrounding environment. Mineralization test in cell-free culture medium showed that many mushroom-like Ca and phosphorus compounds formed on the HT coatings after 5 h, suggesting its high acellular mineralization ability. Primary human osteoblasts attach, spread and proliferate well on both types of coatings. Higher proliferation rate was observed on the HT coatings compared with the SP coatings and uncoated Ti-6Al-4V alloy, probably due to the zinc ions released from the HT coatings. Higher expression levels of Runx2, osteopontin and type I collagen were observed on both types of coatings compared with Ti-6Al-4V alloy, possibly due to the Ca and Si released from the coatings. Results of this study point to the potential use of HT and SP coatings for orthopaedic applications.

The incorporation of strontium and zinc into a calcium-silicon ceramic for bone tissue engineering

In this study we developed novel scaffolds through the controlled substitution and incorporation of strontium and zinc into a calcium-silicon system to form Sr-Hardystonite (Sr-Ca(2)ZnSi(2)O(7), Sr-HT). The physical and biological properties of Sr-HT were compared to Hardystonite (Ca(2)ZnSi(2)O(7)) [HT]. We showed that Sr-HT scaffolds are porous with interconnected porous network (interconnectivity: 99%) and large pore size (300-500 microm) and an overall porosity of 78%, combined with a relatively high compressive strength (2.16+/-0.52 MPa). These properties are essential for enhancing bone ingrowth in load-bearing applications. Sr-HT ceramic scaffolds induced the attachment and differentiation of human bone derived cells (HOB), compared to that for the HT scaffolds. Sr-HT scaffolds enhanced expression of alkaline phosphatase, Runx-2, osteopontin, osteocalcin and bone sialoprotein. The in vivo osteoconductivity of the scaffolds was assessed at 3 and 6 weeks following implantation in tibial bone defects in rats. Histological staining revealed rapid new growth of bone into the pores of the 3D scaffolds with the Sr-HT and HT, relative to the beta-tricalcium phosphate (beta-TCP). In vivo, HT and Sr-HT produced distinct differences in the patterns of degradation of the materials, and their association with TRAP positive osteoclast-like cells with HT appearing more resistant compared to both Sr-HT and beta-TCP.

Preparation and in vitro evaluation of plasma-sprayed Mg(2)SiO(4) coating on titanium alloy

In this paper, chemically synthesized Mg(2)SiO(4) (MS) powder was plasma-sprayed onto a titanium alloy substrate to evaluate its application potentials in biomedicine. The phase composition and surface morphology of the MS coating were analyzed. Results showed that the MS coating was composed mainly of Mg(2)SiO(4) phase, with a small amount of MgO and glass phases. Mechanical testing showed that the coating exhibited good adhesion strength to the substrate due to the close thermal expansion coefficient between the MS ceramic and the titanium alloy substrate. The measured bonding strength was as high as 41.5+/-5.3MPa, which is much higher than the traditional HA coating. In vitro cytocompatibility evaluation of the MS coating was performed using canine bone marrow stem cells (MSCs). The MSCs exhibited good adhesion, proliferation and differentiation behavior on the MS coating surface, which can be explained by the high protein adsorption capability of the MS coating, as well as the stimulatory effects of Mg and Si ions released from the coating. The proliferation rate of the MSCs on MS coating was very close to that on the hydroxylapatite (HA) coating. Alkaline phosphatase (ALP) activity analysis demonstrated that the ALP level of the MSCs on the MS coating remained high even after 21days, implying that the surface characteristics of the coating are beneficial for the differentiation of MSCs. In summary, our results suggest that MS coating might be a new approach to prepare bone implants.

Bioactivation of a cobalt alloy by coating with wollastonite during investment casting

Cobalt alloy samples were bioactivated during investment casting. The cavities of the investment mold were previously coated with wollastonite. Additionally, before coating with wollastonite, some mold cavities were filled out with graphite rods to avoid a chemical reaction between the wollastonite powder and the investment material. Half of the cast samples were heat treated at 1220 degrees C for 1 h. To perform the in vitro bioactivity assessment, the cast and heat-treated samples were immersed in a simulated body fluid solution (SBF) for a period of 21 days. The surface of the samples before and after immersion in SBF was characterized by SEM, EDX, and XRD analyses. During the casting, particles of pseudowollastonite were embedded on the metallic surface. After immersion of the samples in SBF, a ceramic layer was formed on both the alloy obtained by using the investment mold and the alloy obtained by using the graphite-filled cavity. The ceramic layer was thicker on the alloy cast in the investment mold. The layer was identified as hydroxyapatite by XRD analysis, in all the cases. The heat-treated samples after immersion in SBF showed the formation of a thin homogeneous layer consisting of fine grains of apatite.

Cyclic silicate active site and stereochemical match for apatite nucleation on pseudowollastonite bioceramic-bone interfaces

Hydroxyapatite (Ca5(PO4)3(OH)) forms on pseudowollastonite (psW) (alpha-CaSiO3) in vitro in simulated body fluid, human parotid saliva and cell-culture medium, and in vivo in implanted rat tibias. We used crystallographic constraints with ab initio molecular orbital calculations to identify the active site and reaction mechanism for heterogeneous nucleation of the earliest calcium phosphate oligomer/phase. The active site is the planar, cyclic, silicate trimer (Si3O9) on the (001) face of psW. The trimer has three silanol groups (>SiOH) arranged at 60 degrees from each other, providing a stereochemical match for O atoms bonded to Ca2+ on the (001) face of hydroxyapatite. Calcium phosphate nucleation is modeled in steps as hydrolysis of surface Ca-O bonds with leaching of Ca2+ into solution, protonation of the surface Si-O groups to form silanols, calcium sorption as an inner-sphere surface complex and, attachment of HPO4(2-). Our model explains the experimental solution and high resolution transmission electron microscopy data for epitaxial hydroxyapatite growth on psW in vitro and in vivo. We propose that the cyclic silicate trimer is the universal active site for heterogeneous, stereochemically promoted nucleation on silicate-based bioactive ceramics. A critical active site-density and a point of zero charge of the bioceramic less than physiological pH are required for bioactivity.